리나글립틴
Linagliptin is a pharmaceutical compound used as an active pharmaceutical ingredient in products for managing type 2 diabetes. It functions as a dipeptidyl peptidase-4 inhibitor, helping to regulate insulin and glucagon production by the pancreas.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 668270-12-0
7-(2-Butyn-1-yl)-8-[(3R)-3-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-1-piperidinyl]-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione
pharmaceutical intermediate
HALOBETASOL PROPIONATE
topical corticosteroid active pharmaceutical ingredient
Calcium gluconate monohydrate
active pharmaceutical ingredient
(3,4-DIAMINOPHENYL)(4-FLUOROPHENYL)METHANONE
active pharmaceutical ingredient
Tianeptine
atypical tricyclic antidepressant
1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl-4,4,4-d3)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-; 8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butyn-1-yl-4,4,4-d3)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-p
active pharmaceutical ingredient
LINAGLIPTIN, (S)-
active pharmaceutical ingredient
1,1-Dimethylethyl N-[(3R)-1-[7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]carbamate
Boc-protected pharmaceutical intermediate
8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione
LTXREWYXXSTFRX-QGZVFWFLSA-N
CC#CCN1C2=C(N=C1N3CCC[C@H](C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C